Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL1900133 | 重组抗IL-5人源化单克隆抗体注射液 | Recombinant anti-IL-5 Humanized Monoclonal Antibody | Injection | Biological Products(1) | New Drug Application | 2019-11-29 | 三生国健药业(上海)股份有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | In Review | 2019-11-28 | view |